קונבריזה

国: イスラエル

言語: ヘブライ語

ソース: Ministry of Health

有効成分:

BAZEDOXIFENE AS ACETATE 20 MG

から入手可能:

NEOPHARM LTD

ATCコード:

G03XC02

医薬品形態:

COATED TABLETS

投与経路:

PER OS

製:

PFIZER IRELAND PHARMACEUTICALS

治療群:

BAZEDOXIFENE

適応症:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

承認日:

2013-04-01